Antagonists of the prostaglandin D2 receptor CRTH2

Drug News and Perspectives

Volumn 21, Issue 6, 2008, Pages 317-322

  Pettipher, Roy ^a   Hansel, Trevor T ^b  

^a Oxagen Ltd   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; INDOLEACETIC ACID DERIVATIVE; PROSTAGLANDIN D2 RECEPTOR ANTAGONIST; RAMATROBAN; UNCLASSIFIED DRUG; AMINOQUINOLINE DERIVATIVE; CARBAZOLE DERIVATIVE; IMMUNOGLOBULIN RECEPTOR; PROSTAGLANDIN D2; PROSTAGLANDIN D2 RECEPTOR; PROSTAGLANDIN RECEPTOR; SULFONAMIDE;

ALLERGIC DISEASE; ALLERGIC REACTION; ALLERGIC RHINITIS; ARTICLE; ATOPIC DERMATITIS; CHEMOTAXIS; CHRONIC ALLERGIC DISEASE; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG RESPONSE; DRUG SELECTIVITY; GENE ACTIVATION; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; NONHUMAN; PERENNIAL RHINITIS; PHARMACOLOGICAL BLOCKING; T LYMPHOCYTE ACTIVATION; TH2 CELL; ANIMAL; ASTHMA; BASOPHIL; DENDRITIC CELL; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; EOSINOPHIL; GENETICS; HYPERSENSITIVITY; IMMUNOLOGY; MAST CELL; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

AMINOQUINOLINES; ANIMALS; ANTI-ALLERGIC AGENTS; ASTHMA; BASOPHILS; CARBAZOLES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; EOSINOPHILS; HUMANS; HYPERSENSITIVITY; INDOLEACETIC ACIDS; MAST CELLS; PROSTAGLANDIN D2; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; SIGNAL TRANSDUCTION; SULFONAMIDES; TH2 CELLS;

EID: 56249140823     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2008.21.6.1246831     Document Type: Article

References (42)

1. 2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 1982, 129(4): 1627-31.
2. 2 in IgE-mediated reactions in man. Trans Assoc Am Physicians 1982, 95: 221-8.
3. 2 after aspirin challenge supports most cell activation in aspirin-induced airway obstruction. J Allergy Clin Immunol 1996, 98(2): 421-32.
4. 2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. J Allergy Clin Immunol 2003, 111(4): 743-9.
5. 2 in vivo. Thorax 2004, 59(6): 453-5.
6. Reddy, S.T., Tiano, H.F., Langenbach, R., Morham, S.G. and Herschman, H.R. Genetic evidence for distinct roles of COX-1 and COX-2 in the immediate and delayed phases of prostaglandin synthesis in mast cells. Biochem Biophys Res Commun 1999, 265(1): 205-10.
7. 2 into human airways during acute antigen challenge. N Engl J Med 1986, 315(13): 800-4.
8. Naclerio, R.M., Meier, H.L., Kagey-Sobotka, A., Adkinson, N.F. Jr., Meyers, D.A., Norman, P.S. and Lichtenstein, L.M. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983, 128(4): 597-602.
9. Charlesworth, E.N., Kagey-Sobotka, A., Schleimer, R.P., Norman, P.S. and Lichtenstein, L.M. Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen. J Immunol 1991, 146(2): 671-6.
10. 2 by human helper T cell subsets. J Immunol 2000, 164(5): 2277-80.
11. Wang, Y.H., Ito, T., Wang, Y.H. et al. Maintenance and polarization of human t(h)2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. Immunity 2006, 24(6): 827-38.
12. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 2001, 193(2): 255-61.
13. 2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes. Prostaglandins Other Lipid Mediat 2005, 75(1-4): 153-67.
14. 2, a plasma metabolite of prostaglandin D2, causes eosinophil mobilization from the bone marrow and primes eosinophils for chemotaxis. J Immunol 2003, 170(9): 4752-8.
15. 2 are potent activators of human eosinophils. J Immunol 2002, 168(7): 3563-9.
16. 2 metabolism in plasma: Kinetics and relationship with bioactivity on DP1 and CRTH2 receptors. Biochem Pharmacol 2007, 74(1): 107-17.
17. 2, a stable thromhoxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils. J Biol Chem 2004, 279(9): 7663-70.
18. 2α are novel agonists of the chemoattractant receptor, CRTH2. FEBS Lett 2006, 580(2): 373-9.
19. 2 on human eosinophils and basophils. J Pharmacol Exp Ther 2007, 320(1): 173-9.
20. Nagata, K., Hirai, H., Tanaka, K. et al. CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s). FEBS Lett 1999, 459(2): 195-9.
21. Nagata, K., Tanaka, K., Ogawa, K. et al. Selective expression of a novel surface molecule by human Th2 cells in vivo. J Immunol 1999, 162(3): 1278-86.
22. 2 receptor, CRTH2. Br J Pharmacol 2002, 137(8): 1163-72.
23. 2. Biochem Pharmacol 2007, 73(6): 843-53.
24. Kostenis, E. and Ulven, T. Emerging roles of DP and CRTH2 in allergic inflammation. Trends Mol Med 2006, 12(4): 148-58.
25. 2 receptors DP and CRTH2 in human nasal mucosa. Prostaglandins Other Lipid Mediat 2004, 73(1-2): 87-101.
26. 2-related molecules in nasal mucosa of patients with allergic rhinitis. Am J Rhinol 2006, 20(3): 342-8.
27. 2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis. J Invest Dermatol 2002, 119(3): 609-16.
28. Vinall, S.L., Townsend, E.R. and Pettipher, R. A paracrine role for chemoattractant receptor-homologous molecule expressed on T helper type 2 cells (CRTH2) in mediating chemotactic activation of CRTH2(+) CD4(+) T helper type 2 lymphocytes. Immunology 2007, 121(4): 577-84.
29. 2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. J Immunol 2005, 175: 6531-6536.
30. 2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 2001, 98(6): 1942-8.
31. 2 receptor agonists on pulmonary infiltration of eosinophils in Brown Norway rats. J Pharmacol Exp Ther 2005, 313(1): 64-9.
32. 2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor. J Pharmacol Exp Ther 2005, 312(3): 954-60.
33. Gyles, S.L., Xue, L., Townsend, E.R., Wettey, F. and Pettipher, R. A dominant role for chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2) cells (CRTH2) in mediating chemotaxis of CRTH2+ CD4+ Th2 lymphocytes in response to mast cell supernatants. Immunology 2006, 119(3): 362-368.
34. 2 receptor antagonist (Bay u 3405) on nasal symptoms after antigen challenge in sensitized guinea pigs. Int Arch Allergy Immunol 1996, 109(2): 161-6.
35. 2 receptor antagonist BAY-u-3405 on experimental allergic reactions. Prostaglandins 1995, 50(2): 75-87.
36. Takeshita, K., Yamasaki, T., Nagao, K., Sugimoto, H., Shichijo, M., Gantner, F. and Bacon, K.B. CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation. Int Immunol 2004, 16(7): 947-959.
37. 2 receptor CR TH2 attenuates asthma pathology in mouse eosinophilic airway inflammation. Respir Res 2007, 8: 16.
38. 1 and CRTH2 as an approach to treat allergic diseases. Nat Rev Drug Discov 2007, 6(4): 313-25.
39. 2 receptor CRTH2. J Med Chem 2005, 48(20): 6174-7.
40. 1 receptor mediate allergen induced mucus production and airway hyperresponsiveness. Am J Respir Crit Care Med 2005, 163(5): A811.
41. 2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. J Immunol 2006, 177(4): 2621-9.
42. 2 receptor antagonist, on nasal cavity volume and minimum cross-sectional area and nasal mucosal hemodynamics after nasal mucosal allergen challenge inpatients with perennial allergic rhinitis. Acta Otolaryngol Suppl 1998, 537: 32-7.